Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

[Preprint]. 2022 Oct 30:2022.10.27.22281629. [Version 1] doi: 10.1101/2022.10.27.22281629

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.

PMC Copyright notice

Figure 2. — Forest plots of subgroups for odds of severe COVID-19 (hospitalization or death) comparing A) any vs. no outpatient treatment, B) nirmatrelvir/ritonavir vs. no outpatient treatment, and C) monoclonal antibodies vs. no outpatient treatment. Adjusted for continuous age, continuous Charlson Comorbidity Index, continuous estimated glomerular filtration rate, and race. *Model did not converge due to few outcomes.

Figure 2. — Forest plots of subgroups for odds of severe COVID-19 (hospitalization or death) comparing A) any vs. no outpatient treatment, B) nirmatrelvir/ritonavir vs. no outpatient treatment, and C) monoclonal antibodies vs. no outpatient treatment. Adjusted for continuous age, continuous Charlson Comorbidity Index, continuous estimated glomerular filtration rate, and race. *Model did not converge due to few outcomes.